|
|
HIV/AIDS trials under-represented in sub-Saharan research
Oct 6, 2005, 21:48, Reviewed by: Dr.
|
|
People in sub-Saharan Africa carry the heaviest burden of HIV and AIDS, yet very few trials have been conducted on the African continent over the past two decades, say researchers in recent BMJ.
|
By BMJ,
A study in BMJ confirms previous findings that HIV/AIDS trials are under-represented in sub-Saharan research and suggests that publication of trial results continues to be driven by researchers external to the continent.
The team identified and mapped all randomised controlled trials on HIV and AIDS conducted wholly or partly in Africa and reported before 2004.
After extensive searching, they identified 77 trials published or reported from 1987 to 2003. Most of the trials were funded by government agencies outside Africa, pharmaceutical companies and international non-government or inter-government organisations. Few principal investigators were based in African countries and there was no mention of ethical approval or informed consent in 19 and 17 trials, respectively.
The relatively small number of HIV/AIDS trials conducted in Africa is not commensurate with the burden of disease, say the authors. This may reflect a lack of economic ability, political will, or research capacity.
Geographical mapping as an adjunct to prospective trial registration is a useful tool for researchers and decision makers to track existing and future trials, they conclude. 
- British Medical Journal, 1 October 2005 (Vol 331, No 7519)
Read full text of the source article at Journal's Website
Nandi Siegfried, South African Nuffield Medical Fellow, UK Cochrane Centre, Oxford, UK
|
For any corrections of factual information, to contact the editors or to send
any medical news or health news press releases, use
feedback form
Top of Page
|
|
|
|
